On Thursday, Nexalin Technology, Inc (NASDAQ:NXL) (NASDAQ:NXLIW) announced results from a clinical trial of its Deep Intracranial Frequency Stimulation (DIFS) technology for mild Alzheimer’s disease.

Researchers have developed and validated a simple “peel-and-sniff” test that can be completed unsupervised at home to screen for cognitive impairment. It’s well known that impaired olfactory function ...

Researchers are uncovering deeper insights into how the human brain ages and what factors may be tied to healthier cognitive aging, including exercising, avoiding tobacco, speaking a second language ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. WASHINGTON (AP) — It’s the new chant in ...

Online tests of women's reaction times offer insights into cognitive function and could help fill data gaps on early cognitive problems, potentially shedding light on dementia development later in ...

For the first time, a study shows an online assessment can provide a scientific measure of acetylcholine – a key brain chemical, which declines progressively with cognitive aging and even more quickly ...

UCLA researchers have discovered that children with autism have a tell-tale difference on brain tests compared with other children. Specifically, the researchers found that the lower a child's peak ...